Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

InterContinental San Francisco

Nov 05, 2018 7:00 AM - Nov 06, 2018 3:00 PM

888 Howard Street, San Francisco, CA 94103

Real World Evidence Conference

This conference has reached maximum capacity.

Session 7: The Power of Harnessing RWD from Wearables

Session Chair(s)

Gabriela  Lavezzari, PhD, MBA

Gabriela Lavezzari, PhD, MBA

Senior Director, US R&D Policy and Scientific Affairs

GlaxoSmithKline, United States

In today’s healthcare system, we have greater access to technology with infinite amount of data literally at our fingertips. Wearable technology has introduced a new way to collect additional patient information by providing access to the real-world patient experience. This session will investigate case studies of current efforts aimed at using wearable technologies for drug development and regulatory decision-making along with lesson learned from the medical device community on medical devices that won new indications based on RWE.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify areas where medical devices have successfully used RWE for regulatory decision-making
  • Discuss case studies that showcase advances in the use of wearable technologies
  • Identify areas where immediate regulatory policies are needed to streamline the use of wearable technologies for regulatory decision-making in drug development


Pierre-Alexandre  Fournier, MSc

The Power of Harnessing RWD from Wearables: Pierre-Alexandre Fournier, MSc

Co-Founder and CEO

Hexoskin, Canada

George  Savage, MD

The Power of Harnessing RWD from Wearables: George Savage, MD

Co-founder and Chief Medical Officer

Proteus Digital Health, United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.